Lisinopril HCT 20/25mg: Out-of-specification test results
Brand(s)
Last updated
Summary
Product
Sandoz Lisinopril HCT 20/25mg
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| Sandoz Canada | Sandoz Lisinopril HCT | DIN 02302381 | Tablet | HYDROCHLOROTHIAZIDE 25 MG LISINOPRIL (LISINOPRIL DIHYDRATE) 20 MG | PJ5263 PJ5264 |
Issue
Affected lots were recalled following assay stability out-of-specification test results.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Sandoz Canada Incorporated
4600 Rue Armand-Frappier
Saint-Hubert, Quebec
J3Z 1G5
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Recall date
Identification number
RA-78186
Get notified
Receive emails about new and updated recall and safety alerts.